TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $324,978 | -38.0% | 21,007 | -37.0% | 0.00% | 0.0% |
| Q2 2023 | $523,850 | -28.5% | 33,345 | -41.0% | 0.00% | -50.0% |
| Q3 2022 | $733,000 | +252.4% | 56,522 | +281.0% | 0.00% | +100.0% |
| Q2 2022 | $208,000 | -78.9% | 14,836 | -74.7% | 0.00% | -80.0% |
| Q2 2021 | $988,000 | +310.0% | 58,677 | +270.3% | 0.01% | +66.7% |
| Q1 2020 | $241,000 | -96.6% | 15,844 | -95.4% | 0.00% | -93.6% |
| Q1 2019 | $7,022,000 | – | 344,714 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |